Vivo Bio Tech share news, announcements and annual reports
NSE: VIVOBIOTBSE: 511509Pharmaceuticals & BiotechnologySmall Cap
Vivo Bio Tech Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 1994
Last close ₹13.72down ₹0.26 (1.86%)BSE ₹13.83
Share price at the NSE close on 30 Oct 2026. Previous close ₹13.98.
30 Oct: open ₹14.29, high ₹14.29, low ₹13.30
52-week range of BSE trades to 30 Oct 2026
₹12.20Low, 26 Oct 2026₹35.76High, 13 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹30 Cr3,302nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.33
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −3.3%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.60 crore of one-off items, the largest of them in the quarter to Mar 2026.
- −2.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 5.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.72
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 10,91372.6% delivered
Vivo Bio Tech routine notices
182 filed, newest first. Page 4 of 4.
May 2019
Apr 2019
Feb 2019
Jan 2019
Nov 2018
Oct 2018
Sep 2018
Aug 2018
May 2018
Feb 2018
Nov 2017
Sep 2017
May 2017
Jan 2017
Nov 2016
Sep 2016
May 2016
17 May · Routine
Meeting of Board of Directors is scheduled to be held on May 27, 2016, inter alia, to consider the Audited Standalone and Consolidated Financial ....
Feb 2016
2 Feb · Routine
Jan 2016
7 Jan · Routine
Trading Window of the Company shall remain closed from January 07, 2016 to January 13 , 2016 (both days inclusive) in accordance with the code ....
Oct 2015
31 Oct · Routine
Jul 2015
30 Jul · Routine
Meeting of Board of Directors is scheduled to be held on August 12, 2015, inter alia, to consider the Unaudited Financial Results for quarter ended ....
May 2015
19 May · Routine
Meeting of Board of Directors is scheduled to be held on May 28, 2015, to consider the Audited Financial Results for quarter ended and year ended ....
Feb 2015
6 Feb · Routine
Meeting of Board of Directors is scheduled to be held on February 11, 2015, inter alia, to consider the Unaudited Financial Results for the quarter ....
Nov 2014
4 Nov · Routine
Meeting of Board of Directors is scheduled to be held on November 12, 2014, inter alia, to consider the Unaudited Financial Results for the quarter ....
Aug 2014
1 Aug · Routine
Meeting of Board of Directors is scheduled to be held on August 12, 2014, to consider the Unaudited Financial Results for the Quarter ended June 30, 2014. ....
May 2014
20 May · Routine
Meeting of the Board of Directors of the Company will be held on May 28, 2014, inter alia, to consider the following items; 1. To Consider ....